MMP1 may contribute to cancer pain signaling by promoting neuronal sprouting54, activation of PAR1 to sensitize TRPV1 on nociceptors20 and/or by activation of protease activated receptor 2 (PAR2, F2RL1)55,56, a mediator of cancer pain signaling6. The gene discussed is F2RL1; the disease is cancer.